{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:07:43Z","timestamp":1737349663464,"version":"3.33.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,7,25]],"date-time":"2007-07-25T00:00:00Z","timestamp":1185321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2007,10,2]]},"DOI":"10.1007\/s10585-007-9089-3","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T16:28:21Z","timestamp":1185294501000},"page":"521-531","source":"Crossref","is-referenced-by-count":25,"title":["Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response"],"prefix":"10.1007","volume":"24","author":[{"given":"Randall S.","family":"MacGill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Macko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena J.","family":"Mauceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph R.","family":"Weichselbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Richter","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,25]]},"reference":[{"issue":"12","key":"9089_CR1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s000180050255","volume":"54","author":"H Mueller","year":"1998","unstructured":"Mueller H (1998) Tumor necrosis factor as an antineoplastic agent: pitfalls and promises. Cell Mol Life Sci 54(12):1291\u20131298","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"9089_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1470-2045(02)00900-2","volume":"3","author":"RR Weichselbaum","year":"2002","unstructured":"Weichselbaum RR, Kufe DW, Hellman S et al (2002) Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol 3(11):665\u2013671","journal-title":"Lancet Oncol"},{"issue":"4","key":"9089_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2004.01.227","volume":"22","author":"N Senzer","year":"2004","unstructured":"Senzer N, Mani S, Rosemurgy A et al (2004) TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 22(4):592\u2013601","journal-title":"J Clin Oncol"},{"issue":"10","key":"9089_CR4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1245\/ASO.2005.03.023","volume":"12","author":"JM McLoughlin","year":"2005","unstructured":"McLoughlin JM, McCarty TM, Cunningham C et al (2005) TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience and long-term follow-up. Ann Surg Oncol 12(10):825\u2013830","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"9089_CR5","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ et al (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19(16):3635\u20133648","journal-title":"J Clin Oncol"},{"issue":"16","key":"9089_CR6","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE et al (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19(16):3622\u20133634","journal-title":"J Clin Oncol"},{"issue":"2","key":"9089_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/10430340252769798","volume":"13","author":"Y Yamashita","year":"2002","unstructured":"Yamashita Y, Shimada M, Tanaka S et al (2002) Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)\/Apo2L gene therapy for hepatocellular carcinoma. Hum Gene Ther 13(2):275\u2013286","journal-title":"Hum Gene Ther"},{"issue":"5","key":"9089_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","volume":"6","author":"MJ Mastrangelo","year":"1999","unstructured":"Mastrangelo MJ, Maguire HC Jr, Eisenlohr LC et al (1999) Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther 6(5):409\u2013422","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"9089_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.cgt.7700047","volume":"6","author":"C Rochlitz","year":"1999","unstructured":"Rochlitz C, Jantscheff P, Bongartz G et al (1999) Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors. Cancer Gene Ther 6(3):271\u2013281","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"9089_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.gt.3300834","volume":"6","author":"Y Nasu","year":"1999","unstructured":"Nasu Y, Bangma CH, Hull GW et al (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6(3):338\u2013349","journal-title":"Gene Ther"},{"issue":"1","key":"9089_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/hum.2005.16.91","volume":"16","author":"PL Triozzi","year":"2005","unstructured":"Triozzi PL, Strong TV, Bucy RP et al (2005) Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma. Hum Gene Ther 16(1):91\u2013100","journal-title":"Hum Gene Ther"},{"issue":"11","key":"9089_CR12","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.173.11.6635","volume":"173","author":"N Harada","year":"2004","unstructured":"Harada N, Shimada M, Okano S et al (2004) IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol 173(11):6635\u20136644","journal-title":"J Immunol"},{"issue":"12","key":"9089_CR13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/104454903322624966","volume":"22","author":"ML Lucas","year":"2003","unstructured":"Lucas ML, Heller R (2003) IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 22(12):755\u2013763","journal-title":"DNA Cell Biol"},{"issue":"15","key":"9089_CR14","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1089\/hum.1998.9.15-2231","volume":"9","author":"LM Karavodin","year":"1998","unstructured":"Karavodin LM, Robbins J, Chong K et al (1998) Generation of a systemic antitumor response with regional intratumoral injections of interferon gamma retroviral vector. Hum Gene Ther 9(15):2231\u20132241","journal-title":"Hum Gene Ther"},{"issue":"7","key":"9089_CR15","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1167\/iovs.02-1147","volume":"44","author":"H Alizadeh","year":"2003","unstructured":"Alizadeh H, Howard K, Mellon J et al (2003) Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer. Invest Ophthalmol Vis Sci 44(7):3042\u20133051","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"9089_CR16","first-page":"1258","volume":"8","author":"JI Izawa","year":"2002","unstructured":"Izawa JI, Sweeney P, Perrotte P et al (2002) Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Clin Cancer Res 8(4):1258\u20131270","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9089_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.cgt.7700333","volume":"8","author":"G Cao","year":"2001","unstructured":"Cao G, Su J, Lu W et al (2001) Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Ther 8(7):497\u2013505","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"9089_CR18","first-page":"619","volume":"47","author":"MF McDermott","year":"2001","unstructured":"McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol (Noisy-le-grand) 47(4):619\u2013635","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"9","key":"9089_CR19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","volume":"2","author":"MA Palladino","year":"2003","unstructured":"Palladino MA, Bahjat FR, Theodorakis EA et al (2003) Anti-TNF-alpha therapies:the next generation. Nat Rev Drug Discov 2(9):736\u2013746","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"9089_CR20","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.4049\/jimmunol.167.12.6812","volume":"167","author":"EY Kim","year":"2001","unstructured":"Kim EY, Teh HS (2001) TNF type 2 receptor (p75) lowers the threshold of T cell activation. J Immunol 167(12):6812\u20136820","journal-title":"J Immunol"},{"issue":"8","key":"9089_CR21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.188.8.1391","volume":"188","author":"MA Alexander-Miller","year":"1998","unstructured":"Alexander-Miller MA, Derby MA, Sarin A et al (1998) Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1\u20132 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes. J Exp Med 188(8):1391\u20131399","journal-title":"J Exp Med"},{"issue":"6547","key":"9089_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/377348a0","volume":"377","author":"L Zheng","year":"1995","unstructured":"Zheng L, Fisher G, Miller RE et al (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377(6547):348\u2013351","journal-title":"Nature"},{"issue":"11","key":"9089_CR23","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.4049\/jimmunol.165.11.6278","volume":"165","author":"C Brunner","year":"2000","unstructured":"Brunner C, Seiderer J, Schlamp A et al (2000) Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol 165(11):6278\u20136286","journal-title":"J Immunol"},{"issue":"17","key":"9089_CR24","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1089\/10430340152677395","volume":"12","author":"A Kianmanesh","year":"2001","unstructured":"Kianmanesh A, Hackett NR, Lee JM et al (2001) Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity. Hum Gene Ther 12(17):2035\u20132049","journal-title":"Hum Gene Ther"},{"issue":"12","key":"9089_CR25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1349-7006.2000.tb00917.x","volume":"91","author":"H Fujiwara","year":"2000","unstructured":"Fujiwara H, Yamauchi N, Sato Y et al (2000) Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells. Jpn J Cancer Res 91(12):1296\u20131302","journal-title":"Jpn J Cancer Res"},{"issue":"7","key":"9089_CR26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO;2-7","volume":"30","author":"CN Baxevanis","year":"2000","unstructured":"Baxevanis CN, Voutsas IF, Tsitsilonis OE et al (2000) Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice. Eur J Immunol 30(7):1957\u20131966","journal-title":"Eur J Immunol"},{"issue":"5","key":"9089_CR27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.157.5.1919","volume":"157","author":"RK Lee","year":"1996","unstructured":"Lee RK, Spielman J, Zhao DY et al (1996) Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 157(5):1919\u20131925","journal-title":"J Immunol"},{"issue":"21","key":"9089_CR28","first-page":"4824","volume":"55","author":"D Fukumura","year":"1995","unstructured":"Fukumura D, Salehi HA, Witwer B et al (1995) Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 55(21):4824\u20134829","journal-title":"Cancer Res"},{"issue":"3","key":"9089_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/exmp.2001.2368","volume":"70","author":"LA Madge","year":"2001","unstructured":"Madge LA, Pober JS (2001) TNF signaling in vascular endothelial cells. Exp Mol Pathol 70(3):317\u2013325","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"9089_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008390-200102000-00003","volume":"11","author":"I Peter","year":"2001","unstructured":"Peter I, Mezzacasa A, LeDonne P et al (2001) Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3. Melanoma Res 11(1):21\u201330","journal-title":"Melanoma Res"},{"issue":"12","key":"9089_CR31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.cgt.7700268","volume":"7","author":"V Douin-Echinard","year":"2000","unstructured":"Douin-Echinard V, Bornes S, Rochaix P et al (2000) The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Cancer Gene Ther 7(12):1543\u20131556","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"9089_CR32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"A Elsas van","year":"1999","unstructured":"van Elsas A, Hurwitz AA, Allison JP (1999) Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 190(3):355\u2013366","journal-title":"J Exp Med"},{"issue":"1","key":"9089_CR33","first-page":"49","volume":"3","author":"R Geertsen","year":"1999","unstructured":"Geertsen R, Hofbauer G, Kamarashev J et al (1999) Immune escape mechanisms in malignant melanoma. Int J Mol Med 3(1):49\u201357","journal-title":"Int J Mol Med"},{"issue":"3","key":"9089_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1523-1747.1998.00305.x","volume":"111","author":"RC Geertsen","year":"1998","unstructured":"Geertsen RC, Hofbauer GF, Yue FY et al (1998) Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol 111(3):497\u2013502","journal-title":"J Invest Dermatol"},{"key":"9089_CR35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-59259-100-8_4","volume-title":"Tumor models in cancer research","author":"E Alvarez","year":"2002","unstructured":"Alvarez E (2002) B16 murine melanoma. In: Teicher B (ed) Tumor models in cancer research. Human Press, Totowa, NJ, pp 73\u201389"},{"issue":"6","key":"9089_CR36","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.90.6.2419","volume":"90","author":"R Datta","year":"1993","unstructured":"Datta R, Taneja N, Sukhatme VP et al (1993) Reactive oxygen intermediates target CC(A\/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci USA 90(6):2419\u20132422","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"9089_CR37","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.89.21.10149","volume":"89","author":"R Datta","year":"1992","unstructured":"Datta R, Rubin E, Sukhatme V et al (1992) Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 89(21):10149\u201310153","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"9089_CR38","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.88.6.2156","volume":"88","author":"DE Hallahan","year":"1991","unstructured":"Hallahan DE, Sukhatme VP, Sherman ML et al (1991) Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci USA 88(6):2156\u20132160","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9089_CR39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm0895-786","volume":"1","author":"DE Hallahan","year":"1995","unstructured":"Hallahan DE, Mauceri HJ, Seung LP et al (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1(8):786\u2013791","journal-title":"Nat Med"},{"issue":"9","key":"9089_CR40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1535-7163.1167.3.9","volume":"3","author":"CA Lopez","year":"2004","unstructured":"Lopez CA, Kimchi ET, Mauceri HJ et al (2004) Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. Mol Cancer Ther 3(9):1167\u20131175","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"9089_CR41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI0215548","volume":"110","author":"JO Park","year":"2002","unstructured":"Park JO, Lopez CA, Gupta VK et al (2002) Transcriptional control of viral gene therapy by cisplatin. J Clin Invest 110(3):403\u2013410","journal-title":"J Clin Invest"},{"issue":"8","key":"9089_CR42","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/JVI.76.8.3670-3677.2002","volume":"76","author":"D McVey","year":"2002","unstructured":"McVey D, Zuber M, Ettyreddy D et al (2002) Rapid construction of adenoviral vectors by lambda phage genetics. J Virol 76(8):3670\u20133677","journal-title":"J Virol"},{"issue":"9","key":"9089_CR43","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.70.9.6497-6501.1996","volume":"70","author":"DE Brough","year":"1996","unstructured":"Brough DE, Lizonova A, Hsu C et al (1996) A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol 70(9):6497\u20136501","journal-title":"J Virol"},{"key":"9089_CR44","unstructured":"Kovesdi I, Ransom SC (2003) United States Patent #6,514,943: method and composition for preserving viruses. GenVec, Inc., USA"},{"issue":"1","key":"9089_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00391826","volume":"105","author":"G Carlsson","year":"1983","unstructured":"Carlsson G, Gullberg B, Hafstrom L (1983) Estimation of liver tumor volume using different formulas \u2013 an experimental study in rats. J Cancer Res Clin Oncol 105(1):20\u201323","journal-title":"J Cancer Res Clin Oncol"},{"issue":"17","key":"9089_CR46","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1158\/1078-0432.CCR-04-0296","volume":"10","author":"AJ Mundt","year":"2004","unstructured":"Mundt AJ, Vijayakumar S, Nemunaitis J et al (2004) A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities. Clin Cancer Res 10(17):5747\u20135753","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9089_CR47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.cgt.7700518","volume":"9","author":"H Rasmussen","year":"2002","unstructured":"Rasmussen H, Rasmussen C, Lempicki M et al (2002) TNFerade biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene. Cancer Gene Ther 9(11):951\u2013957","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"9089_CR48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiology.219.1.r01ap38166","volume":"219","author":"EF Donnelly","year":"2001","unstructured":"Donnelly EF, Geng L, Wojcicki WE et al (2001) Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 219(1):166\u2013170","journal-title":"Radiology"},{"issue":"3","key":"9089_CR49","first-page":"512","volume":"35","author":"TP Butler","year":"1975","unstructured":"Butler TP, Gullino PM (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35(3):512\u2013516","journal-title":"Cancer Res"},{"key":"9089_CR50","volume-title":"The anatomy of the laboratory mouse","author":"MJ Cook","year":"1965","unstructured":"Cook MJ (1965) The anatomy of the laboratory mouse. Academic Press, London"},{"issue":"4","key":"9089_CR51","first-page":"243","volume":"16","author":"J Lindena","year":"1983","unstructured":"Lindena J, Trautschold I (1983) Ductus thoracicus lymph in mice. 1. A technique for cervical approach. Lymphology 16(4):243\u2013246","journal-title":"Lymphology"},{"issue":"Pt 3","key":"9089_CR52","first-page":"369","volume":"109","author":"NL Tilney","year":"1971","unstructured":"Tilney NL (1971) Patterns of lymphatic drainage in the adult laboratory rat. J Anat 109(Pt 3):369\u2013383","journal-title":"J Anat"},{"issue":"7","key":"9089_CR53","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1073\/pnas.88.7.2830","volume":"88","author":"M Lewis","year":"1991","unstructured":"Lewis M, Tartaglia LA, Lee A et al (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88(7):2830\u20132834","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"9089_CR54","first-page":"4311","volume":"56","author":"HJ Mauceri","year":"1996","unstructured":"Mauceri HJ, Hanna NN, Wayne JD et al (1996) Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res 56(19):4311\u20134314","journal-title":"Cancer Res"},{"issue":"5","key":"9089_CR55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/107327489500200503","volume":"2","author":"IJ Fidler","year":"1995","unstructured":"Fidler IJ (1995) Melanoma metastasis. Cancer Control 2(5):398\u2013404","journal-title":"Cancer Control"},{"issue":"4","key":"9089_CR56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.20079","volume":"86","author":"U Leiter","year":"2004","unstructured":"Leiter U, Meier F, Schittek B et al (2004) The natural course of cutaneous melanoma. J Surg Oncol 86(4):172\u2013178","journal-title":"J Surg Oncol"},{"issue":"2","key":"9089_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cncr.11464","volume":"98","author":"SD Nathanson","year":"2003","unstructured":"Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98(2):413\u2013423","journal-title":"Cancer"},{"issue":"8","key":"9089_CR58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12(8):895\u2013904","journal-title":"Nat Med"},{"issue":"21","key":"9089_CR59","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/jnci\/93.21.1638","volume":"93","author":"HE Wiley","year":"2001","unstructured":"Wiley HE, Gonzalez EB, Maki W et al (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93(21):1638\u20131643","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9089_CR60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10555-006-8506-4","volume":"25","author":"R Essner","year":"2006","unstructured":"Essner R (2006) Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma. Cancer Metastasis Rev 25(2):257\u2013267","journal-title":"Cancer Metastasis Rev"},{"issue":"7069","key":"9089_CR61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820\u2013827","journal-title":"Nature"},{"issue":"7069","key":"9089_CR62","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/438750b","volume":"438","author":"PS Steeg","year":"2005","unstructured":"Steeg PS (2005) Cancer biology: emissaries set up new sites. Nature 438(7069):750\u2013751","journal-title":"Nature"},{"issue":"6835","key":"9089_CR63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","volume":"411","author":"SA Rosenberg","year":"2001","unstructured":"Rosenberg SA (2001) Progress in human tumour immunology and immunotherapy. Nature 411(6835):380\u2013384","journal-title":"Nature"},{"issue":"7","key":"9089_CR64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.6004\/jnccn.2006.0058","volume":"4","author":"A Ribas","year":"2006","unstructured":"Ribas A (2006) Update on immunotherapy for melanoma. J Natl Compr Canc Netw 4(7):687\u2013694","journal-title":"J Natl Compr Canc Netw"},{"issue":"7 Pt 2","key":"9089_CR65","doi-asserted-by":"crossref","first-page":"2353s","DOI":"10.1158\/1078-0432.CCR-05-2503","volume":"12","author":"MB Atkins","year":"2006","unstructured":"Atkins MB (2006) Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin Cancer Res 12(7 Pt 2):2353s\u20132358s","journal-title":"Clin Cancer Res"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9089-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9089-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:53:50Z","timestamp":1737323630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,25]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10,2]]}},"alternative-id":["9089"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9089-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2007,7,25]]}}}